Login to Your Account

Funding Pivotal Studies

SINE of an Active Compound: Karyopharm Bags $48 Million

By Brian Orelli
BioWorld Insight Contributing Writer

Tuesday, May 28, 2013

Karyopharm Therapeutics Inc. announced last week that it raised $48.2 million in a Series B financing, a rather large round these days, especially for a Series B.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription